For the selected examples, KDM2B inhibited the growth, proliferation and metastasis of ovarian cancer,13 pancreatic cancer14 and bladder cancer.26 However, whether and how its activities might be modulated to facilitate tumour progression is still unclear. The gene discussed is KDM2B; the disease is urinary bladder cancer.